{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-007320","form_type":"8-K","ticker":"RCUS","cik":"0001724521","company_name":"Arcus Biosciences, Inc.","filed_at":"2023-03-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.318703+00:00","generated_at":"2026-06-18T05:38:06.525399+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Arcus Biosciences appoints Alexander Azoy as Principal Accounting Officer","bullets":["Alexander Azoy appointed Principal Accounting Officer effective March 9, 2023.","Robert C. Goeltz II remains CFO but ceases as Principal Accounting Officer.","Azoy previously VP of Finance since Oct 2020; prior CFO at Sienna Biopharmaceuticals.","Azoy entered standard severance/change of control agreement and severance program."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-007320","json":"https://secwatch.observer/filing/0000950170-23-007320.json","markdown":"https://secwatch.observer/filing/0000950170-23-007320.md","text":"https://secwatch.observer/filing/0000950170-23-007320.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1724521/000095017023007320/0000950170-23-007320-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1724521/000095017023007320/rcus-20230309.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T05:38:06.525399+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"15ab100f47","claim":"Robert C. Goeltz II changed role as Principal Accounting Officer at Arcus Biosciences, Inc..","evidence_excerpt":"Concurrent with Mr. Azoy’s appointment as the Company’s Principal Accounting Officer, Robert C. Goeltz II, the Company’s Chief Financial Officer (and in such role was the Company’s Principal Financial Officer), ceased to function as the Company’s Principal Accounting Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1724521/000095017023007320/0000950170-23-007320-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"ceased to function as"},{"label":"Role","value":"Principal Accounting Officer"}],"fact_type":"executive_change"},{"claim_id":"cf90fd9458","claim":"Alexander Azoy was appointed as Principal Accounting Officer at Arcus Biosciences, Inc..","evidence_excerpt":"On March 9, 2023, the Board of Directors (the “Board”) of Arcus Biosciences, Inc. (the “Company”) appointed Alexander Azoy to serve as the Company’s Principal Accounting Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1724521/000095017023007320/0000950170-23-007320-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Principal Accounting Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}